Paper24464643
NTPDase3 and ecto-5'-nucleotidase/CD73 are differentially expressed during mouse bladder cancer progression.
Rockenbach L and 8 others. Purinergic Signal, 2014. Cited by 23 papers, by iCite.
Cite this record
ConductScience Library. NTPDase3 and ecto-5'-nucleotidase/CD73 are differentially expressed during mouse bladder cancer progression. Papers, record 24464643. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24464643
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- NTPDase3 and ecto-5'-nucleotidase/CD73 are differentially expressed during mouse bladder cancer progression.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| 5'-Nucleotidase | Major topic |
| Disease Progression | Major topic |
| Gene Expression Regulation, Neoplastic | Major topic |
| Pyrophosphatases | Major topic |
| Urinary Bladder Neoplasms | Major topic |
| Animals | |
| Male | |
| Mice | |
| Mice, Inbred BALB C |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Canadian Institutes of Health Research | Canada | PubMed |
Source PubMed
References61
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 18636315 | The role of ecto-5'-nucleotidase/CD73 in glioma cell line proliferation. | Mol Cell Biochem | 2008 | https://conductscience.org/library/papers/18636315 | PubMed |
| 2 | 23249382 | Determination of the differential expression of mitochondrial long non-coding RNAs as a noninvasive diagnosis of bladder cancer. | BMC Urol | 2012 | https://conductscience.org/library/papers/23249382 | PubMed |
| 3 | 23046227 | Opportunities and challenges for anti-CD73 cancer therapy. | Immunotherapy | 2012 | https://conductscience.org/library/papers/23046227 | PubMed |
| 4 | 23292999 | Smoking is associated with lower age, higher grade, higher stage, and larger size of malignant bladder tumors at diagnosis. | Int J Cancer | 2013 | https://conductscience.org/library/papers/23292999 | PubMed |
| 5 | 20179192 | CD73 on tumor cells impairs antitumor T-cell responses: a novel mechanism of tumor-induced immune suppression. | Cancer Res | 2010 | https://conductscience.org/library/papers/20179192 | PubMed |
| 6 | 18670642 | Molecular credentialing of rodent bladder carcinogenesis models. | Neoplasia | 2008 | https://conductscience.org/library/papers/18670642 | PubMed |
| 7 | 17146560 | A model of hemorrhagic cystitis induced with acrolein in mice. | Braz J Med Biol Res | 2006 | https://conductscience.org/library/papers/17146560 | PubMed |
| 8 | 22287455 | High expression of CD73 as a poor prognostic biomarker in human colorectal cancer. | J Surg Oncol | 2012 | https://conductscience.org/library/papers/22287455 | PubMed |
| 9 | 17823293 | Disordered purinergic signaling inhibits pathological angiogenesis in cd39/Entpd1-null mice. | Am J Pathol | 2007 | https://conductscience.org/library/papers/17823293 | PubMed |
| 10 | 964550 | Different susceptibilities of the urinary bladder epithelium of animal species to three nitroso compounds. | Gan | 1976 | https://conductscience.org/library/papers/964550 | PubMed |
| 11 | 21858682 | Involvement of ecto-5'-nucleotidase/CD73 in U138MG glioma cell adhesion. | Mol Cell Biochem | 2012 | https://conductscience.org/library/papers/21858682 | PubMed |
| 12 | 20661219 | Extracellular adenosine triphosphate and adenosine in cancer. | Oncogene | 2010 | https://conductscience.org/library/papers/20661219 | PubMed |
| 13 | 15565330 | Immunotherapy for superficial bladder cancer. | Cancer Immunol Immunother | 2005 | https://conductscience.org/library/papers/15565330 | PubMed |
| 14 | 21533188 | Expression and distribution of ectonucleotidases in mouse urinary bladder. | PLoS One | 2011 | https://conductscience.org/library/papers/21533188 | PubMed |
| 15 | 20080644 | Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis. | Proc Natl Acad Sci U S A | 2010 | https://conductscience.org/library/papers/20080644 | PubMed |
| 16 | 19513500 | Anti-tumor effect of cimetidine via inhibiting angiogenesis factors in N-butyl-N-(4-hydroxybutyl) nitrosamine-induced mouse and rat bladder carcinogenesis. | Oncol Rep | 2009 | https://conductscience.org/library/papers/19513500 | PubMed |
| 17 | 15247774 | Characteristics of adenosine triphosphate [corrected] release from porcine and human normal bladder. | J Urol | 2004 | https://conductscience.org/library/papers/15247774 | PubMed |
| 18 | 19372055 | Differential ectonucleotidase expression in human bladder cancer cell lines. | Urol Oncol | 2010 | https://conductscience.org/library/papers/19372055 | PubMed |
| 19 | 17671792 | Ecto-5'-nucleotidase promotes invasion, migration and adhesion of human breast cancer cells. | J Cancer Res Clin Oncol | 2008 | https://conductscience.org/library/papers/17671792 | PubMed |
| 20 | 23176070 | Purinergic signalling in the lower urinary tract. | Acta Physiol (Oxf) | 2013 | https://conductscience.org/library/papers/23176070 | PubMed |
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42014997 | ENTPD3 as a novel regulator of endometrial receptivity: suppressing EMT via the ATP-P2Y2 axis in patients with recurrent implantation failure. | Cell Mol Biol Lett | 2026 | https://conductscience.org/library/papers/42014997 | PubMed |
| 40232523 | Evaluation of hepatic cancer stem cells (CD73+, CD44+, and CD90+) induced by diethylnitrosamine in male rats and treatment with biologically synthesized silver nanoparticles. | Mol Biol Rep | 2025 | https://conductscience.org/library/papers/40232523 | PubMed |
| 39567465 | Expression and Hormonal Regulation of Entpd3 at Various Estrous Cycle Stages in the Mouse Uterus. | Reprod Sci | 2025 | https://conductscience.org/library/papers/39567465 | PubMed |
| 37906424 | Preclinical evaluation of bozepinib in bladder cancer cell lines: modulation of the NPP1 enzyme. | Purinergic Signal | 2025 | https://conductscience.org/library/papers/37906424 | PubMed |
| 36964277 | Characterization of purinergic signaling in tumor-infiltrating lymphocytes from lower- and high-grade gliomas. | Purinergic Signal | 2024 | https://conductscience.org/library/papers/36964277 | PubMed |
| 36676954 | Urinary ATP Levels Are Controlled by Nucleotidases Released from the Urothelium in a Regulated Manner. | Metabolites | 2022 | https://conductscience.org/library/papers/36676954 | PubMed |
| 35429327 | High P2X6 receptor expression in human bladder cancer predicts good survival prognosis. | Mol Cell Biochem | 2022 | https://conductscience.org/library/papers/35429327 | PubMed |
| 35079944 | Structure-activity features of purines and their receptors: implications in cell physiopathology. | Mol Biomed | 2022 | https://conductscience.org/library/papers/35079944 | PubMed |
| 34381563 | High CD39 expression is associated with the non-muscle-invasive phenotype of human bladder cancer. | Oncotarget | 2021 | https://conductscience.org/library/papers/34381563 | PubMed |
| 33879578 | Ectonucleotidases in Inflammation, Immunity, and Cancer. | J Immunol | 2021 | https://conductscience.org/library/papers/33879578 | PubMed |
| 31754326 | GATA Binding Protein 3 Boosts Extracellular ATP Hydrolysis and Inhibits Metastasis of Breast Cancer by Up-regulating Ectonucleoside Triphosphate Diphosphohydrolase 3. | Int J Biol Sci | 2019 | https://conductscience.org/library/papers/31754326 | PubMed |
| 31698766 | Impaired Expression of Ectonucleotidases in Ectopic and Eutopic Endometrial Tissue Is in Favor of ATP Accumulation in the Tissue Microenvironment in Endometriosis. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31698766 | PubMed |
| 29663369 | Specific blockade CD73 alters the "exhausted" phenotype of T cells in head and neck squamous cell carcinoma. | Int J Cancer | 2018 | https://conductscience.org/library/papers/29663369 | PubMed |
| 29305710 | Ecto-5'-nucleotidase/CD73 contributes to the radiosensitivity of T24 human bladder cancer cell line. | J Cancer Res Clin Oncol | 2018 | https://conductscience.org/library/papers/29305710 | PubMed |
| 29184552 | Multifaceted Effects of Extracellular Adenosine Triphosphate and Adenosine in the Tumor-Host Interaction and Therapeutic Perspectives. | Front Immunol | 2017 | https://conductscience.org/library/papers/29184552 | PubMed |
| 26543299 | CD73 Predicts Favorable Prognosis in Patients with Nonmuscle-Invasive Urothelial Bladder Cancer. | Dis Markers | 2015 | https://conductscience.org/library/papers/26543299 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/24464643
GET https://conductscience.org/api/papers/v1/24464643/references?page=2